Focal Nodular Hyperplasia (FNH) is the second most hepatic tumor next to hemangioma predominantly affecting women. It is a benign regenerative nodule having an unencapsulated well-defined mass with fibrovascular septae and proliferating bile ductules. Gadoxetic acid is a hepatocyte specific MR contrast agent which is known to be specific for the identifying FNH. Congenital vascular malformation and enlargement due to hormone stimulation is being considered as the main cause of FNH. The central stellate fibrovascular scar is a typical diagnostic imaging feature of FNH and the atypical pathological findings of FNH include large lesions multiple in number, internal necrosis, haemorrhagic foci and fatty infiltration. The atypical imaging features include nonenhancement of the central scar, calcification of the lesion, nonvisualized central scar and pseudocapsular enhancement on delayed imaging. For the accurate diagnosis of FNH, study of atypical radiologic features of FNH in correlation with pathological findings is the most essential. The macroscopic and the microscopic pathognomic changes should be taken as helpful points in the diagnosis of FNH. The main objective of this study is to recognize and understand the typical and atypical imaging patterns observed in CT and MR imaging of FNH with pathological correlation which avoids the necessity of biopsy and further investigations.
Introduction
Focal Nodular Hyperplasia (FNH) is the second most benign hepatic tumor which affects both male and female, but predominantly women (80% -95%) during third-fifth decade of life [1] [2] . FNH accounts only 2% of hepatic tumors that occurs in childhood (0 -10 years) [3] . Gadoxetic acid, which is taken up by hepatocytes and excreted via bile duct and kidney, is a hepatocyte specific MR contrast agent which is known to be specific for the identifying FNH [4] - [6] . FNH is a benign regenerative nodule comprising disorganized growing normal hepatocytes having an unencapsulated well-defined mass with fibrovascular septae and proliferating bile ductules [7] [8] .
Congenital vascular malformation and enlargement due to hormone stimulation is being considered as the cause of FNH and the use of oral contraceptives is also to be taken in consideration as its causative association. [1] . However FNH is expected to arise as a consequence of pre-existing spider-like arterial structures with heterogenous blood flow resulting a hyperplastic hepatocyte response [7] .
The central stellate fibrovascular scar is a typical diagnostic imaging feature of FNH which accounts only about 50% of FNH lesion.
Pathological Findings
The atypical pathological findings of FNH; which are very rare; includes large lesions multiple in number, internal necrosis, haemorrhagic foci, fatty infiltration and the atypical imaging features includes non-enhancement of the central scar, calcification of the lesion, nonvisualized central scar, pseudocapsular enhancement on delayed imaging. Despite the advancement in imaging techniques like triple phase spiral CT and fast MR imaging, it becomes sometimes not easy to differentiate FNH because of its atypical features. So for the accurate diagnosis of FNH, study of atypical radiologic features of FNH in correlation with pathological findings is the most essential. Core needle biopsy helps in confirmatory diagnosis of FNH which shows lack of portal tracts, normal central vein and bile duct drainage with damaged normal architecture [9] .
The Macroscopic and Microscopic Findings
The macroscopic pathognomic changes like homogenous central stellate scar, radiating septa with rare presence of necrosis and hemorrhagic foci with excellent arterial blood supply; and also the microscopic pathognomic changes like fibrous septa, area of hepatocellular proliferation, fibromuscular hyperplasia, myxomatous changes with inflammatory cells should be taken as helpful points in the diagnosis of FNH [1] [2] . As FNH has no life threating complications or malignant potentials, surgical intervention or further evaluation is not needed at the time of diagnosis [2] .
Objective
The main objective of this study is to prevent the common and uncommon imaging patterns observed in CT and MR imaging of FNH with pathological correlation.
Generally, FNH has a solitary nodule smaller than 5 cm in diameter which is lobulated and well circumscribed without capsule [1] [2] . The presence of a central stellate scar with radiating fibrous septa, dividing the lesion into nodules of normal hepatocytes arranged abnormally is the pathognomonic macroscopic feature (Figure 1) . The fibrous septae and the cellular areas of hepatocellular proliferation are the microscopic features of FNH (Figure 2 ).
Typical CT and MRI Findings

CT Findings
On unenhanced CT, FNH is seen as solitary lesion with central focal low attenuation scar surrounded by well defined homogenous area showing mass effect; the attenuation of which is similar to that of surrounding liver parenchyma. This typical feature of FNH is found in approximately 20% of patients [10] .
During the arterial phase of hepatic enhancement, FNH is homogenously enhanced (96%) with the exception of the central scar. In portal phase of hepatic enhancement, the lesion becomes iso-attenuating to the surrounding liver parenchyma but the central scar remains as low attenuated spot. Unexpectedly the central scar show enhancement in delayed phase which is due to the presence of abubdant myxomatous stroma [11] . 
MRI Findings
On T1WI, the FNH shows iso-or hypointensity (94% -100%) and on T2WI the lesion shows hyper or isointensity (94% -100%) and homogeneity (96%). At the same time the central scar is of decreased signal on T1WI and of increased signal (84%) on T2WI because of the bile ductules, edematous myxomatous tissue and its vascular supply [1] [12] .
Following intravenous gadolinium chelates, the whole lesion enhances expect the central scar in arterial phase but the central scar shows enhancement on delayed phase [11] .
Hepatic adenoma, which is a differential diagnosis of FNH, is distinguished from FNH by the presence of heterogenous MR SI due to intralesional hemorrhage or fat component [13] .
Also for central scar of fibrolamellar HCC is distinguished from FNH by presence of hypointense on T1WI and T2WI without definite enhancement [14] .
Atypical CT and MR Findings
The Size of the Tumor
Atypical presentation may be showed by the size of the tumor if the size exceeds 5 cm in diameter although majority possess the size less than 5 cm. In study by Ishak and Rabin of the 130 patients with FNH, 85% of patients was found to have a single nodule less than 5 cm in diameter, 12% had a FNH which measured between 5 and 10 cm and only 3% had the lesion greater than 10 cm. Larger tumors if measure greater than 5 cm may cause symptoms because the lesions may expand the Glisson's capsule or cause focal mass effect on surrounding structures [15] . Large tumors may cause abdominal pain or awareness of the presence of an abdominal mass. Abdominal pain is usually caused by the expansion of the Glisson's capsule or focal mass effect on surrounding organs or vascular structures (Figure 3) .
Multiplicity of Lesions
Another parameter of FNH showing atypical presentation is multiplicity of lesions. Although mostly FNH is solitary, 22% (8 patients out of 37 patients) of FNH were found to have multiple lesions in study of Vilgrain et al. [12] . Two lesions in each of six patients, three in one patient and four in another patient were found (Figure 4 and Figure 5 ).
Hemorrhage and Necrosis
Some of FNH is found having hemorrhage and necrosis which are unusual findings [1] . Ischemic necrosis of FNH occurs more rarely which has been reported in 3 women who have history of oral contraceptive use [16] . Estrogens may cause vascular changes in FNH (Figure 6 and Figure 7) .
Abnormal Enhancement Pattern
On Gd-EOB-DTPA-enhanced MRI, T1WI of FNH may show homogenously intense enhancement in early phase, subtle washout during the delayed phase and a low signal perfusion defect in the hepatobiliary phase which is similar to the findings of an expanding nodular HCC. Some atypical findings of FNH of patients of he patitis B may include hepatic nodule taking complete enhancement during the early arterial phase of MDCT, the delayed phase without definite washout of the contrast enhancement although the portal venous phase shows iso-attenuation with T2WI showing a high SI and mild diffusion restriction on DWI (b-factor 800) apparent different coefficient imaging with Gadoxetic acid enhanced MRI showing early intense homogenous enhancement and subtle peripheral washout during portal phase and ring like peripheral enhancement with central washout during equilibrium phase and hepatobiliary phase; which gives vague differential diagnosis like well-differentiated HCC, a high grade dysplastic nodule and hepatic adenoma. In this situation, we need to go for USG guided biopsy for confirm diagnosis [6] [17] [18].
Intralesional Steatosis
Intralesional steatosis in FNH is thought to have association with several hepatic injury like alcoholic toxicity, obesity and protein malabsorbtion. But fatty infiltration in FNH without underlying cause has been found very rarely and has been documented only twice in the literature [19] . In earlier reports, hepatic steatosis was thought to be result of the patient's underlying disease while describing the presence of fat in FNH (Figure 8 and Figure  9 ).
The Undetectable Central Scar
It is found that the central scar of FNH is undetectable on CT (16% -40%) and on MRI (22%) due to its extremely tiny size [1] [2] [10] [12] . This non-visualized scar only can be noticed when there is deformity of liver configuration or presence of mass effects like displacement of adjacent hepatic vessels (Figure 10 and Figure  11 ).
Fibrous Thick Hyaline Pseudocapsule
Fibrous thick hyaline pseudocapsule surrounding FNH can be seen enhanced which is very rare [20] . The presence of pseudocapsule in FNH may suggest that underlying lesion is growing slowly, the capsule in this cases is fibrous, thick and hyaline (Figure 12 and Figure 13) ; however in some cases it may be confused with the eccentric compression of the lesion on hypertrophied feeding vessels.
The Nonenhanced Central Scar
In delayed phase on contrast-enhanced CT and on T1W MR, the central scar of FNH may still appear hypodense and hypointense respectively while may mimick the collagenous scar in hepatic adenoma, HCC, fibrolamellar carcinoma or intrahepatic cholagiocarcinoma [20] . After administration of constrast material, appearance of the nonenhanced central scar may be due to obliterative vascular hyperplasia of the central arteries [1] (Figure 14 and Figure 15 ). 
Conclusion
Identification of FNH is essential for management of the lesion. The diagnosis of FNH includes both pathological and imaging features. The pathological features include macroscopic and microscopic features. The Imaging features include CT and MRI features with or without contrast enhancement. Despite the advancement in imaging modalities in recent few years, diagnosing FNH may be a challenging task if there is unexpectedly the presence of atypical imaging features of FNH, although FNH usually presents with typical imaging features. So understanding and recognizing the atypical imaging features is an important aspect for radiologist in diagnosing FNH correctly which helps to avoid the necessity of biopsy and further studies. Differentiating FNH from malignant lesions avoiding unnecessary intervention is also a valuable aspect of this review. Each of these diagnostic procedures has own limitations and clinicians should be aware of them.
